Sonya C Chapman
6PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 27, 2026
Longitudinal Tumor Size and Survival Modeling for Exposure-Response Analysis of Drugs with Frequent Dose Reductions: Dose Justification of Abemaciclib in Patients with Metastatic Breast Cancer.Emmanuel Chigutsa, Sonya C Chapman, P Kellie Turner
|Oct 30, 2025
Application of Physiologically-Based Pharmacokinetic Modeling to Support Drug Labeling: Prediction of CYP3A4-Mediated Pirtobrutinib-Drug Interactions.Dan-Dan Tian, Stephen D Hall, Sonya C Chapman
|Nov 06, 2022
Abemaciclib in combination with pembrolizumab for HR+, HER2- metastatic breast cancer: Phase 1b study.Hope S Rugo, Peter Kabos, J Thad Beck
|Aug 28, 2020
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study.Karen A Autio, Christopher A Klebanoff, David Schaer
|Jul 23, 2020
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer.Sara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun
|Sep 19, 2019
Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy.Jian Du, Lei Yan, Raquel Torres
Pageof 1
Frequent Collaborators
1 joint publications
Karsten Boehnke
1 joint publications
Sean G Buchanan
1 joint publications
Thomas Bachelot
1 joint publications
Ahmad Awada
1 joint publications
Arlene Chan
1 joint publications
Nancy U Lin
1 joint publications
John Sae Wook Kauh
1 joint publications
Matthew Adamow
1 joint publications
Jill S Gluskin
1 joint publications
Shanu Modi
